Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Chronic inflammatory demyelinating polyneuropathy

Launch
Not announced
Last updated
143 sources

Product information and disease descriptionProduct description

Product information

75 evidence topics · 34 sources

Average sales price and wholesale acquisition cost

Not applicable.

Effect of Claseprubart on quality measures

No evidence found.